Ethics, evidence, and cost in newborn screening

Area of Science:

• Public Health
• Medical Ethics
• Genetics

Background:

• Newborn screening programs aim to detect genetic and metabolic disorders early.
• Current policies are established to identify a range of treatable conditions in infants.
• The ethical and economic implications of screening protocols warrant critical evaluation.

Purpose of the Study:

• To evaluate current newborn screening policies based on established ethical and practical criteria.
• To assess whether existing screening protocols align with principles of effectiveness, cost-benefit analysis, and human rights.

Main Methods:

• Analysis of existing newborn screening guidelines and policies.
• Review of evidence regarding the effectiveness of screened disorders.
• Ethical framework application to assess fairness and human rights considerations.

Main Results:

• Current newborn screening policies lack sufficient evidence of real-world effectiveness for all included disorders.
• Opportunity costs associated with current screening practices are not adequately considered.
• Fair distribution of costs and benefits, alongside respect for human rights, is not consistently met.

Conclusions:

• Newborn screening policies require significant revision to align with evidence-based practice and ethical standards.
• A more rigorous approach is needed to ensure screening programs are effective, equitable, and rights-respecting.
• Future policy development must integrate comprehensive assessments of effectiveness, cost, and ethical implications.